222 related articles for article (PubMed ID: 38361692)
1. Correlation of Computed Tomography (CT) Severity Score With Laboratory and Clinical Parameters and Outcomes in Coronavirus Disease 2019 (COVID-19).
Pamulapati BK; Nanjundappa RK; Chandrabhatla BS; Roohi SU; Palepu S
Cureus; 2024 Jan; 16(1):e52324. PubMed ID: 38361692
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography Severity Scoring on High-Resolution Computed Tomography Thorax and Inflammatory Markers With COVID-19 Related Mortality in a Designated COVID Hospital.
Ravindra Naik B; Sakalecha AK; B N S; A C; Kale R M; Uhasai K
Cureus; 2022 Apr; 14(4):e24190. PubMed ID: 35592193
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
[TBL] [Abstract][Full Text] [Related]
6. Relationship of Computed Tomography Severity Score With Patient Characteristics and Survival in Hypoxemic COVID-19 Patients.
Yanamandra U; Shobhit S; Paul D; Aggarwal B; Kaur P; Duhan G; Singh A; Srinath R; Saxena P; Menon AS
Cureus; 2022 Mar; 14(3):e22847. PubMed ID: 35382199
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Chest CT and RT-PCR Testing in India's Second COVID - 19 Wave: A Retrospective Cohort Study.
Jyoti D; Mehta V
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443458
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Biochemical, and Radiological Presentation of RT-PCR-Positive vs RT-PCR-Negative SARS-CoV-2 Pneumonia Requiring ICU Care: An Observational, Cross-Sectional, Single-Center Study in Kalaburagi, Kalyana Karnataka.
Waddankeri S; Arora K; Mallasure N; Konin B; Mangshetty BG
Cureus; 2022 Nov; 14(11):e31493. PubMed ID: 36532907
[TBL] [Abstract][Full Text] [Related]
9. Utility of Neutrophil-Lymphocyte Ratio (NLR) as an Indicator of Disease Severity and Prognostic Marker among Patients with Covid-19 Infection in a Tertiary Care Centre in Bangalore - A Retrospective Study.
PrakashRao VV
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443517
[TBL] [Abstract][Full Text] [Related]
10. Correlations between chest-CT and laboratory parameters in SARS-CoV-2 pneumonia: A single-center study from Italy.
Orlacchio A; Gasparrini F; Roma S; Ravà MS; Salvatori E; Morosetti D; Cossu E; Legramante JM; Paganelli C; Bernardini S; Minieri M
Medicine (Baltimore); 2021 Apr; 100(14):e25310. PubMed ID: 33832103
[TBL] [Abstract][Full Text] [Related]
11. Association of COVID-19 Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Cycle Threshold Value With Surrogate Markers of Disease Severity.
John JE; Amle DB; Takhelmayum R; Gopal N; Mishra M; Joshi P; Rathod B; Gadkari R
Cureus; 2022 Nov; 14(11):e31034. PubMed ID: 36475201
[TBL] [Abstract][Full Text] [Related]
12. Chest HRCT Severity Scores among Hospitalized Patients with COVID-19.
Paul D; Bhuiya MI; Paul UK; Dey B; Khan MK
Mymensingh Med J; 2022 Jul; 31(3):819-825. PubMed ID: 35780369
[TBL] [Abstract][Full Text] [Related]
13. Chest CT severity score as a predictor of mortality and short-term prognosis in COVID-19.
Jayachandran AK; Nelson V; Shajahan ME
J Family Med Prim Care; 2022 Aug; 11(8):4363-4367. PubMed ID: 36353028
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
[TBL] [Abstract][Full Text] [Related]
16. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
Shakeeb N; Varkey P; Hynse A; Mandlecha A
Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494
[TBL] [Abstract][Full Text] [Related]
18. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
19. The Association of Psychosocial Manifestations and Quality of Life With Inflammatory Markers in SARS-CoV-2 Patients: A Study From a Dedicated COVID-19 Tertiary Care Hospital.
Kumar K; Srivastava S; Meena A; Avasthi RK; Kashyap B
Cureus; 2023 Jul; 15(7):e42341. PubMed ID: 37621784
[TBL] [Abstract][Full Text] [Related]
20. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
